Cargando…

Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: Should humoral responses be monitored? A position article

Taking into account higher risk of severe coronavirus disease 2019 or death among patients with cancer, as well as impaired immunogenicity after anti-SARS-CoV-2 vaccines, in addition to waning immunity, booster dosing appears mandatory in this patient population. This review sought to provide reason...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barrière, Jérôme, Carles, Michel, Audigier-Valette, Clarisse, Re, Daniel, Adjtoutah, Zoubir, Seitz-Polski, Barbara, Gounant, Valérie, Descamps, Diane, Zalcman, Gérard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674546/ https://www.ncbi.nlm.nih.gov/pubmed/35016032 http://dx.doi.org/10.1016/j.ejca.2021.12.011

Ejemplares similares

Préconisations pour protéger les patients de la filière oncologique face au variant Omicron
por: Barrière, Jérôme, et al.
Publicado: (2022)

Omicron variant: A clear and present danger for patients with cancer
por: Barrière, J., et al.
Publicado: (2022)

Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies
por: Re, Daniel, et al.
Publicado: (2022)

Immunotherapy, the promise for present and future of malignant pleural mesothelioma (MPM) treatment
por: Gounant, Valérie, et al.
Publicado: (2021)

Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses
por: Buscot, Matthieu, et al.
Publicado: (2023)

Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses
por: Gounant, Valérie, et al.
Publicado: (2022)

MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial
por: Maille, Elodie, et al.
Publicado: (2019)

Nous devons respecter le schéma vaccinal anti-SARS-CoV-2 sans décalage chez les patients atteints de cancer sous traitement
por: Barrière, Jérôme, et al.
Publicado: (2021)

Letter to Editor “Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs”: Important concerns on the validity of this article
por: Barrière, Jérôme, et al.
Publicado: (2023)

Impaired immunogenicity of BNT162b2 anti-SARS-CoV-2 vaccine in patients treated for solid tumors
por: Barrière, J., et al.
Publicado: (2021)

Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer
por: Barrière, Jérôme, et al.
Publicado: (2021)

Safe and effective use of nivolumab for treating lung adenocarcinoma associated with sporadic lymphangioleiomyomatosis: a rare case report
por: Pluvy, Johan, et al.
Publicado: (2019)

Biomarkers of Response to Etoposide-Platinum Chemotherapy in Patients with Grade 3 Neuroendocrine Neoplasms
por: Lacombe, Caroline, et al.
Publicado: (2021)

NKX2.1 (TTF1) germline mutation associated with pulmonary fibrosis and lung cancer
por: Borie, Raphael, et al.
Publicado: (2021)

Scientific Integrity Requires Publishing Rebuttals and Retracting Problematic Papers
por: Barrière, Jérôme, et al.
Publicado: (2022)

Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab
por: Herbreteau, Guillaume, et al.
Publicado: (2020)

A new KIF5B–ERBB4 gene fusion in a lung adenocarcinoma patient
por: Guenzi, Edouard, et al.
Publicado: (2021)

Transthoracic lung biopsy for pulmonary nodules ≤20 mm in routine clinical care
por: Lissavalid, Emilie, et al.
Publicado: (2022)

Measuring Walking Speed Failed to Predict Early Death and Toxicity in Elderly Patients with Metastatic Non-Small-Cell Lung Cancer (NSCLC) Selected for Undergoing First-Line Systemic Treatment: An Observational Exploratory Study
por: Aregui, Amélie, et al.
Publicado: (2022)

Low baseline IFN-γ response could predict hospitalization in COVID-19 patients
por: Cremoni, Marion, et al.
Publicado: (2022)

Grade 3–4 Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer (NSCLC) Patients Are Correlated with Better Outcome: A Real-Life Observational Study
por: Guezour, Nadia, et al.
Publicado: (2022)

Epidermal growth factor receptor-mutant non-small cell lung Cancer and Choroidal metastases: long-term outcome and response to epidermal growth factor receptor tyrosine kinase inhibitors
por: Bouchez, Clémentine, et al.
Publicado: (2020)

Farther Account of the Case Detailed in Article Third in This Number
Publicado: (1846)

The Truth Shall Make Us Free—Third Article
por: Allen, J. H.
Publicado: (1896)

Clinical and Molecular Characterization of Patients with Mucopolysaccharidosis Type I in an Algerian Series
por: Tebani, Abdellah, et al.
Publicado: (2016)

Both Humoral and Cellular Immune Responses to SARS-CoV-2 Are Essential to Prevent Infection: a Prospective Study in a Working Vaccinated Population from Southern France
por: Graça, Daisy, et al.
Publicado: (2023)

Patients avec cancers thoraciques et COVID-19 : au cœur de la tempête: Patients with chest cancer and COVID-19: at the heart of the storm
por: Gounant, V., et al.
Publicado: (2021)

Virtuous laughter: we should teach medical learners the art of humor
por: Oczkowski, Simon
Publicado: (2015)

As Well as Proper Citation, References in Biomedical Articles Should Be Accurate
por: Siebers, Robert
Publicado: (2013)

Humoral Response to SARS-CoV-2 mRNA Vaccine in Heart Transplant Recipients up to 4 Months After the Third Vaccine Injection
por: Ferré, V.M., et al.
Publicado: (2022)

Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study
por: Cremoni, Marion, et al.
Publicado: (2021)

Proposals for managing patients with thoracic malignancies during COVID-19 pandemic
por: Girard, N., et al.
Publicado: (2020)

That’s not funny! – But it should be: effects of humorous emotion regulation on emotional experience and memory
por: Kugler, Lisa, et al.
Publicado: (2015)

Humoral Response to the Third-Dose COVID-19 Vaccination in Patients with Hematological Malignancy
por: Ikeda, Daisuke, et al.
Publicado: (2022)

Another Article About E‐Cigarettes: Why Should I Care?
por: Cummings, K. Michael, et al.
Publicado: (2018)

Patient perceptions and understanding of treatment instructions for ovarian stimulation during infertility treatment
por: Barrière, Paul, et al.
Publicado: (2019)

Third Case of Visceral Leishmaniasis in COVID-19: Mini Review Article
por: Colomba, Claudia, et al.
Publicado: (2022)

A third injection of the BNT162b2 mRNA COVID-19 vaccine in kidney transplant recipients improves the humoral immune response
por: Masset, Christophe, et al.
Publicado: (2021)

A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT‐0701 MAPS phase 3 trial
por: Maille, Elodie, et al.
Publicado: (2022)

Should we always improve adherence to antimicrobial treatment? I don’t think we should
por: Llor, Carles
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_78l583b8g2lquq2gt03cgvbojt